Canada markets open in 9 hours 26 minutes

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.8300-0.3600 (-11.29%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.67M
Enterprise Value 98.57k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)55.50
Price/Book (mrq)0.68
Enterprise Value/Revenue -655.82
Enterprise Value/EBITDA -0.01

Trading Information

Stock Price History

Beta (5Y Monthly) 1.83
52-Week Change 3-47.00%
S&P500 52-Week Change 323.10%
52 Week High 36.7500
52 Week Low 31.7500
50-Day Moving Average 33.0993
200-Day Moving Average 33.1884

Share Statistics

Avg Vol (3 month) 32.85k
Avg Vol (10 day) 31.18k
Shares Outstanding 52.71M
Implied Shares Outstanding 62.71M
Float 81.13M
% Held by Insiders 120.77%
% Held by Institutions 141.34%
Shares Short (Apr 15, 2024) 420.18k
Short Ratio (Apr 15, 2024) 45.12
Short % of Float (Apr 15, 2024) 41.02%
Short % of Shares Outstanding (Apr 15, 2024) 40.74%
Shares Short (prior month Mar 15, 2024) 423.49k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3May 16, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-38.34%
Return on Equity (ttm)-115.85%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -9.58M
Net Income Avi to Common (ttm)-12.59M
Diluted EPS (ttm)-5.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.57M
Total Cash Per Share (mrq)2.98
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.85
Book Value Per Share (mrq)4.56

Cash Flow Statement

Operating Cash Flow (ttm)-21.25M
Levered Free Cash Flow (ttm)-9.52M